中文
中文
为了病患而驱动的创新
Patient-first cell therapy innovation

科学论文
SCIENTIFIC PUBLICATION
  • 12.242018
    Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer.
    Jia Q., Wu W., Wang Y., Alexander P.B., Sun C., Gong Z., Cheng J., Sun H., Guan Y., Xia X., Yang L., Yi X., Wan Y., Wang H., Futreal P.A., Li Q.-J.*, Zhu B.* (2018) Local mutational diversity drives intratumoral immune heterogeneity in non-small cell
  • 12.232018
    Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells.
    Zhao L., He R., Long H., Guo B., Jia Q., Qin D., Liu S.-Q., Wang Z., Xiang T., Zhang J., Tan Y., Huang J., Chen J., Wang F., Xiao M., Gao J., Yang X., Zeng H., Wang X., Hu C., Alexander P. B., Symonds A.L.J., Yu J., Wan Y., Li Q.-J.*, Ye L.*, Zhu B
123
查看更多

Copyright © 2019 天科雅生物医药科技有限公司

粤公网安备 44011502000528号

粤ICP备20056630号 Powered by vancheer
关于天科雅
研究与发展
产品及临床
新闻与媒体
招贤纳士

Copyright © 2019 天科雅生物医药科技有限公司

粤公网安备 44011502000528号

粤ICP备20056630号 Powered by vancheer